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We have investigated the possible role of second messengers on inositol homeostasis in NT2-
N cells, human central nervous system neurons obtained by terminal differentiation of tera-
tocarcinoma precursors. Uptake of inositol into NT2-N neurons was inhibited ∼ 10% by
protein kinase C (PKC) activation but was unaffected by either the presence of cyclic nu-
cleotide analogs or changes in the intracellular concentration of Ca2+. Efflux of inositol from
NT2-N neurons was enhanced in hypotonic buffer but virtually eliminated by inclusion of the
Cl− channel blocker 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid, a result which indi-
cates the involvement of a volume-sensitive organic osmolyte-anion channel. Volume-sensitive
inositol efflux was stimulated ∼ 30% following activation of PKC or elevation of the cytosolic
Ca2+ concentration but was unaffected by protein kinase A activation. These results suggest
that whereas inositol uptake into NT2-N neurons is relatively refractory to regulation, vol-
ume-sensitive inositol efflux may be significantly affected by intracellular signaling events.
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tability (1). Consequently, the brain adapts to persist-
ent osmotic stress by regulating the intracellular con-
centration of “compatible” organic osmolytes such as
myo-inositol, sorbitol, taurine, betaine, and glycero-
phosphorylcholine (2–4). Among these osmolytes, inosi-
tol is thought to be one of the most critical in mammalian
brain (4,5).
Dysregulation of inositol transport in the brain is
implicated in the pathogenesis of a number of clinical
disorders. For example, because of decreases in cere-
bral inositol concentration during prolonged hypona-
tremia, the rapid correction of blood osmolality with
isotonic fluids may result in brain dehydration and
myelinolysis; conversely, the rapid correction of chro-
nic hypernatremia is frequently associated with life-
threatening cerebral edema (6). These problems may,
at times, be circumvented by the gradual correction of
plasma tonicity (36 days) (5). Another instance of the
pathophysiological role of inositol transport in brain is
INTRODUCTION
Volume regulation in the human brain is essential
to offset disturbances in blood osmolality. Although
acute osmotic stress is countered by fluctuations in the
intracellular concentration of electrolytes such as KCl,
these fluctuations, if prolonged, would result in enzy-
matic dysfunction and disruption of membrane exci-
stroke. Local cerebral ischemia causes cytotoxic neu-
ronal swelling and a reduction in cellular ATP (7).
Since inositol efflux requires the nonhydrolytic asso-
ciation of ATP with the volume-sensitive organic os-
molyte-anion channel (VSOAC), decreased cellular
ATP availability is associated with decreased inositol
release and exacerbates neuronal swelling (8).
In spite of its potential clinical relevance, the regu-
lation of inositol transport in neurons of the human
central nervous system (CNS) is unknown. Inositol
transport is comprised of uptake, which is selective and
actively driven by the Na+/myo-inositol cotransporter,
and efflux, which is nonselective and passively mediated
by the Cl− channel VSOAC. The diversity of regulatory
mechanisms among cell types such as primary astrocyte
(9), C6 glioma (10), retinal pigment epithelial (RPE)
(11), bovine lens epithelial (12), inner medullary col-
lecting duct (13,14), and Madin-Darby canine kidney
(MDCK) (15) cells suggests that the modulation of in-
ositol transport is cell type-specific, although protein ki-
nases A and C as well as intracellular Ca2+ have emerged
as frequent regulators. Notably, Ca2+ is a prime regula-
tor of inositol release from the kidney (16) but plays lit-
tle or no role in CNS glia (9,10). Since little is known of
the regulation of inositol homeostasis in either primary
culture CNS neurons or neuroblastoma cells, we have
characterized inositol transport in NT2-N neurons. NT2-
N cells are obtained from the human testicular terato-
carcinoma cell line NT2, which is induced to irreversibly
differentiate to a post-mitotic neuronal phenotype by
means of retinoic acid treatment (17–19). NT2-N cells
have a distinctly neuronal morphology, express a host of
CNS neuron-specific proteins (19,20), and form func-
tional synapses (21). We have recently shown that the
neuronal differentiation of NT2 cells is accompanied by
a 10-fold increase in inositol concentration, a result con-
sistent with an increase in the uptake of inositol and a de-
crease in the efflux of this polyol (22). The present
results indicate that, in these cells, it is primarily the ef-
flux of inositol that is subject to regulation by protein
kinase C (PKC) and intracellular Ca2+.
EXPERIMENTAL PROCEDURE
Materials. myo-[3H]Inositol (80 Ci/mmol) was purchased
from Amersham (Arlington Heights, IL). myo-Inositol, 4β-phorbol
12β-myristate 13α-acetate (PMA), 1,2-dioctanoyl-sn-glycerol (C8:0)
(DiC8), 4α-phorbol 12,13-didecanoate (αPDD), N6, 2′-O-dibutyryl-
adenosine 3′:5′-cyclic monophosphate (dibutyryl cAMP, db-cAMP),
8-bromoguanosine 3′:5′-cyclic monophosphate (8Br-cGMP), 4,4′-
diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS), L-glutamate,
N-methyl-D-aspartate (NMDA), all trans-retinoic acid, uridine,
5-fluoro-2′-deoxyuridine, and cytosine β-D-arabinofuranoside were
obtained from Sigma Chemical (St. Louis, MO). 2-Butyn-1-
ammonium, N,N,N-trimethyl-4-(2-oxo-1-pyrrolidinyl) iodide (oxo-
tremorine-M, oxo-M) was from Research Biochemicals International
(Natick, MA). Bisindolylmaleimide I (BIM), ionomycin, and 1,2-
bis(2-aminophenoxy)-ethane-N,N,N′,N′-tetraacetic acid / tetra(ace-
toxymethyl)-ester (BAPTA/AM) were from Calbiochem (La Jolla,
CA). Powdered Dulbecco’s modified Eagle’s medium (DMEM),
0.25% (wt/vol) trypsin, 10X trypsin-EDTA [0.5% (wt/vol) trypsin,
5.3 mM EDTA], 1X Versene (0.2 g/l of EDTA in phosphate-
buffered saline), and Hanks’ balanced salt solution were purchased
from GIBCO (Grand Island, NY). Fetal calf serum was obtained
from Summit Biotechnology (Fort Collins, CO). Matrigel basement
membrane matrix and poly-D lysine hydrobromide were from Col-
laborative Biomedical Products (Bedford, MA). Tissue culture sup-
plies were obtained from Corning Glass Works (Corning, NY) and
Sarstedt (Newton, NC). Bicinchoninic acid protein assay reagents
were from Pierce (Rockford, IL). UniverSol-ES liquid scintillation
cocktail was obtained from ICN (Costa Mesa, CA). C6 glioma cells
were a gift from Dr. W. R. Mancini (University of Michigan).
Cell Culture.Differentiated human NT2-N neurons were gen-
erated from NT2 teratocarcinoma cells as previously described (22).
In brief, NT2 cells were treated with 10 µM retinoic acid twice per
week for five weeks. After retinoic acid treatment, cells were rinsed
with 1X Versene, detached from 75-cm2 flasks with 0.25% (wt/vol)
trypsin, and replated into 225-cm2 flasks (replate I). Two days later,
cells were rinsed with Hanks’ balanced salt solution and treated with
1X trypsin-EDTA. Flasks were struck repeatedly to remove NT2-N
neurons, which were seeded on 6-cm dishes previously coated with
10 µg/ml poly-D-lysine and 1:36 Matrigel in DMEM (replate II). For
the first three weeks after replate II, neurons were maintained in
DMEM, supplemented with 10% fetal calf serum, that also con-
tained 10 µM 5-fluoro-2′-deoxyuridine, 10 µM uridine, and 1 µM
cytosine β-D-arabinofuranoside. After three weeks, NT2-N cells
were maintained in conditioned medium obtained from replate I.
Inositol Uptake. Inositol uptake was measured as described
(22,23). NT2-N neurons, attached to 6-cm dishes, were washed with
4 × 2 ml of buffer A (142 mM NaCl, 5.6 mM KCl, 2.2 mM CaCl2,
3.6 mM NaHCO3, 1 mM MgCl2, 30 mM HEPES, and 5.6 mM D-
glucose, pH 7.4) and allowed to equilibrate in 2.55 ml of the same
buffer at 37°C for 30 min. Reactions were initiated by the addition of
300 µl of drug and 150 µl of [3H]inositol (250 µM; 5 µCi/µmol) and
allowed to proceed at 37°C for 1 h. To terminate the reactions, the
buffer was rapidly aspirated and the cells washed with 5 × 2 ml of ice-
cold buffer A containing 1 mM inositol and lysed with 2 × 1 ml of
ice-cold 6% (wt/vol) trichloroacetic acid. Lysates were transferred to
test tubes on ice and centrifuged at 2,400 g for 5 min at 4°C. Radio-
activity in 0.5 ml of supernatant was determined by liquid scintillation
spectrometry after the addition of 5 ml of UniverSol scintillation fluid.
The pellet was dissolved in a solution of 5% (wt/vol) sodium dodecyl
sulfate and 0.1 M NaOH and analyzed for protein.
Inositol Efflux.Efflux of inositol was determined essentially as
described (22). NT2-N neurons, attached to 6-cm dishes, were prela-
beled overnight with 5 µCi/ml myo-[ 3H]inositol. Cells were then
washed with 3 × 2 ml of isotonic (142 mM NaCl; 330–338 mOsm),
hypotonic (67 mM NaCl; 202–216 mOsm), or intermediate-osmo-
lality buffer A and incubated in 4 ml of drug in the same buffer at
37°C. Aliquots of buffer (50–100 µl) were periodically removed and
radioactivity determined. To terminate the reactions, the buffer
was rapidly aspirated and the cells washed with 3 × 2 ml of ice-
cold buffer A and lysed with 2 × 1 ml of ice-cold 6% (wt/vol)
trichloroacetic acid. Radioactivity in the supernatant was deter-
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mined as previously described. Total [3H]inositol originally present
in the neurons was calculated as the sum of that recovered in the
buffer and that remaining in the lysate at the end of the assay. Ef-
flux at any given time was then expressed as the ratio of radioactiv-
ity present in buffer to total [3H]inositol.
Data Analysis.Data shown represent mean ± SEM values for
the number (n) of independent experiments done. Duplicate or trip-
licate values were obtained for each condition measured. Student’s
two-tailed t tests were used to evaluate the statistical differences be-
tween the means of paired or unpaired sets of data.
RESULTS
Inositol Uptake into NT2-N Neurons Is Inhibited
by Protein Kinase C.The regulation of [3H]inositol up-
take into NT2-N cells was measured during 1-h incu-
bations with various drugs and second messenger
analogs. Uptake was not affected by either the mus-
carinic cholinergic agonist oxotremorine-M or by cell-
permeable activators of protein kinases A and G (PKA
and PKG), db-cAMP and 8Br-cGMP, respectively (Fig.
1). A small but significant reduction of inositol uptake
(∼ 11%) was observed, however, during the activation of
PKC with 100 nM PMA. In addition, exposure of cells
to 1 µM PMA overnight to downregulate basal PKC ac-
tivity (24) resulted in the stimulation of inositol uptake
by approximately 12%. Twenty-four hour preincubation
with hypertonic medium (∼ 500 mOsm with NaCl) to
stimulate transcription of the Na+/myo-inositol cotrans-
porter (25,26) did not affect the relative magnitude of
these changes (data not shown). Neither the chelation of
intracellular Ca2+ with BAPTA/AM nor the stimulation
of Ca2+ influx with the Ca2+ ionophore ionomycin had
significant effects on inositol uptake in NT2-N cells
(Fig. 1). As reported for primary mouse astrocytes (27),
neither acute (10 mM, 1 h) nor chronic (1 mM, 4 d) in-
cubation with Li+ caused a change in the rate of uptake.
Efflux of Inositol from NT2-N Neurons Is Mediated
by VSOAC.Osmolyte efflux from most tissues occurs
via the nonselective Cl− channel VSOAC, whose pres-
ence is verified by the stimulation of efflux during hy-
potonic exposure and the inhibition of efflux by Cl−
channel blockers (5,9,28). To assess the volume sensi-
tivity of inositol release from NT2-N cells, [3H]inositol
efflux was measured over the course of 6 h as a func-
tion of osmotic strength. Buffer osmolality was varied
from 330 mOsm (isotonic) to 216 mOsm (hypotonic) by
alteration of NaCl concentration; this range was within
that previously used to demonstrate the effect of hypo-
tonicity on inositol efflux (1,11,13,29). Inositol efflux
was relatively unchanged from 330 to 300 mOsm, and
although there was a tendency for increased efflux at
272 mOsm, this increase only reached significance at
6 h (Fig. 2). Significantly enhanced release was ob-
served at 244 and 216 mOsm throughout the course of
the assay. Since [3H]inositol efflux was most prominent
at 216 mOsm, this osmolality was used to test the effect
of protein kinase activation and intracellular Ca2+ con-
centration in subsequent experiments. Incubation with
200 µM DIDS, a Cl− channel blocker that inhibits
VSOAC-mediated osmolyte transport (9,13), resulted in
the complete inhibition of volume-sensitive [3H]inositol
efflux from NT2-N neurons, in the presence or absence
of PMA (see below). Collectively, these results indicate
that volume-sensitive inositol efflux from NT2-N neu-
rons is mediated by VSOAC.
Volume-Sensitive Inositol Efflux Is Stimulated by
Protein Kinase C and Intracellular Ca2+. Inositol efflux
is regulated by PKA, PKC, and intracellular Ca2+ in nu-
merous cell types (10,11,13,16). As a first analysis of
the regulation of volume-sensitive inositol efflux from
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Fig. 1. Protein kinase C regulates myo-inositol uptake into NT2-N
neurons. NT2-N neurons, adherent to 6-cm dishes, were washed
four times with buffer and incubated with [3H]inositol (250 µM;
5 µCi/µmol) with or without the agents indicated for 1 h.
Concentrations were as follows: Oxo-M, db-cAMP, 8Br-cGMP = 
1 mM; PMA, acute = 100 nM; PMA, chronic = 1 µM given overnight
before the experiment; BAPTA/AM = 50 µM; ionomycin = 1 µM; Li +,
acute = 10 mM; Li +, chronic = 1 mM given 4 d before the experiment.
Results are expressed as the mean percentage ± SEM of inositol
uptake in the presence of a given agent with respect to control for
the number of experiments indicated in parentheses. *Different from
control, p < 0.05.
NT2-N neurons, cells were prelabeled overnight with
[3H]inositol, and efflux was subsequently measured
over the course of 6 h in either isotonic (∼ 330 mOsm)
or hypotonic (∼ 210 mOsm) buffer in the presence or ab-
sence of 1 mM db-cAMP or 100 nM PMA (Fig. 3).
Under isotonic conditions, efflux of [3H]inositol was
unaffected by either PKA or PKC activation and oc-
curred at the approximately linear rate of 2.1 ± 0.1%/h
(n = 3–5), a value in accordance with the previously re-
ported low rate of release from these cells (22). Under
hypotonic conditions, as previously shown (see Fig. 2),
inositol efflux from NT2-N neurons was significantly
elevated at all time points. Although incubation with
db-cAMP had no effect on hypotonic efflux, incubation
with PMA caused a marked stimulation (∼ 130% of hy-
potonic control at 6 h; n = 6).
The role of PKC in the activation of volume-
sensitive inositol efflux was characterized in an addi-
tional series of measurements. Hypotonically-induced
inositol efflux from neurons was unaffected by incuba-
tion with the muscarinic agonist oxo-M, although as
previously observed, efflux was significantly increased
in the presence of PMA (p < 0.0001; Fig. 4). Prein-
cubation (1 h) with 5 µM BIM, a competitive PKC
antagonist, attenuated the PMA-mediated activation of
volume-sensitive efflux at 6 h. Conversely, the non-
phorbol PKC-activating diacylglycerol DiC8, although
less efficacious than PMA, elicited an increase in
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Fig. 2. Hypotonicity regulates myo-inositol efflux from NT2-N
neurons. NT2-N neurons, adherent to 6-cm dishes, were incubated
with medium containing 5 µCi/ml [3H]inositol overnight. Cells were
washed three times with buffer of varying osmolality and incubated
at 37°C. Aliquots of extracellular buffer were periodically removed
and radioactivity was determined. Data are expressed as [3H]inositol
recovered in the extracellular buffer relative to [3H]inositol present
initially in the cells. s = 330 mOsm (isotonic); j = 300 mOsm; n =
272 mOsm; d = 244 mOsm; h = 216 mOsm. Results shown are
mean ± SEM values for three separate experiments. *Different from
isotonic control, p < 0.05. **Different from isotonic control, p < 0.01.
***Different from isotonic control, p < 0.001.
Fig. 3. Protein kinase C regulates volume-sensitive myo-
inositol efflux from NT2-N neurons. [3H]Inositol efflux from NT2-
N neurons was determined as previously described. s = isotonic
buffer (330–338 mOsm) alone; j = isotonic buffer + 1 mM db-
cAMP; n = isotonic buffer + 100 nM PMA; d = hypotonic buffer
(202–216 mOsm) alone; h = hypotonic buffer + 1 mM db-cAMP;
m = hypotonic buffer + 100 nM PMA. Results shown are mean 
± SEM values for three to six separate experiments. *Different from
isotonic control, p < 0.05. **Different from isotonic control, p <
0.01. ++Different from hypotonic control, p < 0.01. +++Different from
hypotonic control, p < 0.001.
inositol efflux at 6 h (p < 0.03), whereas the inactive
phorbol ester αPDD had no effect at either time point
(p > 0.05).
The regulation of inositol efflux from NT2-N neu-
rons by Ca2+ was also determined. In the presence of
50 µM BAPTA/AM, the hypotonic release of [3H]inos-
itol appeared to be increased in rate but not in magni-
tude, such that the large increase observed at 1 h had
returned to control values by 6 h (Fig. 4). In contrast,
1 µM ionomycin produced a sustained increase (∼ 25%)
in volume-sensitive inositol efflux at both time points.
Similar data were obtained in the presence of the diva-
lent cation ionophore A23187 (2.5 µM; data not
shown). Inositol efflux from NT2-N cells was not af-
fected by the presence of 100 µM or 1 mM concentra-
tions of either glutamate or NMDA (data not shown).
DISCUSSION
myo-Inositol efflux from NT2-N neurons was sen-
sitive to regulation by second messengers, whereas in-
ositol uptake was relatively refractory to modulation.
Neither the muscarinic agonist oxotremorine-M, nor
cell-permeable activators of PKA or PKG, nor changes
in the intracellular concentration of Ca2+ had any effect
on neuronal inositol uptake. Conversely, muscarinic ag-
onists, PKA activators, and Ca2+ ionophores have been
reported to elicit either decreases (15,23) or increases
(11) in the uptake of inositol into other cell types. Al-
though inositol uptake into NT2-N neurons was inhib-
ited by PKC activation, a result consistent among
diverse cell types (11,15,23), this inhibition (10%) was
less robust than has been reported elsewhere (20–30%).
Taken collectively, these data indicate that the second
messenger regulation of inositol uptake into NT2-N
neurons is minimal compared to that in glia and non-
neural cells.
Osmolyte efflux during a period of decreased
tonicity is mediated by the volume-sensitive organic
osmolyte-anion channel (VSOAC), which has not been
definitively identified but has been characterized as a
relatively nonselective, outwardly-rectified Cl− channel
(5,30). Involvement of VSOAC is frequently inferred
from the stimulation of osmolyte efflux by hypotonicity
and the inhibition of efflux by Cl− channel blockers.
NT2-N cells demonstrated [3H]inositol efflux that in-
creased during successive decreases in tonicity and
whose volume-sensitive component was eliminated by
200 µM DIDS. Thus, VSOAC most likely mediates hy-
potonic inositol efflux from human CNS neurons, as it
does from human (5) and rat glia (9) as well as RPE (11)
and inner medullary collecting duct cells (13).
Volume-sensitive [3H]inositol efflux from NT2-N
neurons was stimulated (125–130% of control) by PKC
activation and increased intracellular Ca2+ concentra-
tion but not by PKA activation. Conversely, isotonic ef-
flux was unaffected by PKC stimulation, a finding that
emphasizes the importance of PKC signaling in the os-
motic stress response. PKC activation increases organic
osmolyte (10,11) as well as electrolyte (31) efflux in nu-
merous cell systems and is thought to result in the phos-
phorylation of VSOAC itself or putative regulatory
proteins such as pICln (32; but see 33 and 34). Ca
2+ typ-
ically regulates efflux of inositol in cells of renal (16)
but not of glial (9,10) origin. In the presence of
BAPTA/AM, [ 3H]inositol efflux from NT2-N cells oc-
curred more rapidly but to the same ultimate extent as
the hypotonic control. Increased efflux at early time
points has also been observed in C6 glioma cells pre-
treated with BAPTA/AM (10). In contrast, ionomycin
generated a sustained increase (∼ 25%) in inositol efflux
from NT2-N neurons. By way of comparison, Strange
et al. (10) had previously reported no effect of 1 µM
ionomycin on inositol efflux from C6 glioma cells, and
we observed a decrease in volume-sensitive [3H]inosi-
tol efflux from C6 glioma cells at 6 h under similar con-
ditions (68 ± 6%, n = 3, p < 0.05; data not shown). This
result suggests that neurons and glia are differentially
regulated by intracellular Ca2+ with respect to volume-
sensitive inositol efflux. Although activation of PKA
stimulates volume-sensitive [3H]inositol efflux in RPE
cells (11), it is without effect in MDCK cells (16), as is
observed in NT2-N neurons.
In summary, the regulation of inositol transport in
differentiated human NT2-N neurons occurs primarily at
the level of volume-sensitive efflux. Since the intracel-
lular concentration of inositol in neurons seems to be
maximal under isotonic conditions (∼ 20 mM) (22), there
may be a greater capacity to lose than to gain inositol
with respect to the extracellular environment; hence, up-
take is relatively refractory to regulation, whereas efflux
is stimulated by hypotonicity and can be modulated by
second messenger production. Small global decreases in
tonicity, protracted over the course of weeks or months
in hyponatremic patients, or large local increases in
volume-sensitive inositol efflux within the brain during
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Fig. 4. Protein kinase C and Ca2+ stimulate, and DIDS inhibits,
volume-sensitive myo-inositol efflux from NT2-N neurons. [3H]
Inositol efflux from NT2-N neurons was determined as previously
described. Concentrations of Oxo-M, PMA, BAPTA/AM, and iono-
mycin were the same as described in the legend to Fig. 1. Other
concentrations were as follows: PMA/BIM = 50 µM BIM given 1 h
before the experiment followed by 100 nM PMA given at the start of
the assay; DIDS = 200 µM; PMA/DIDS = 200 µM DIDS and 100 nM
PMA given concurrently at the start of the assay; DiC8 = 50 µM;
αPDD = 100 nM. Results are expressed as the mean percentage
± SEM of inositol efflux in the presence of a given agent with respect
to control for the number of experiments indicated in parentheses.
Open bars, 1 h incubation. Hatched bars, 6 h incubation. *Different
from hypotonic control, p < 0.05. **Different from hypotonic control,
p < 0.01. ***Different from hypotonic control, p < 0.001. +Different
from PMA alone, p < 0.05. ++Different from PMA alone, p < 0.01.
stroke, could contribute to clinical pathophysiology.
Further knowledge of these neuronal inositol transport
processes may thus prove useful in the development of
therapeutic agents to treat blood Na+ imbalances and
cerebral ischemia.
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